HLA class I and II molecules present peptides from exogenous pathogens to CD8 and CD4‐positive T‐cells, respectively; we therefore believe that HLA associations with EBV‐positive cHL are likely to reflect qualitative and/or quantitative differences in the T‐cell response to EBV. The gene discussed is CD4; the disease is classic Hodgkin lymphoma.